Compare JXN & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXN | BIO |
|---|---|---|
| Founded | 1961 | 1952 |
| Country | United States | United States |
| Employees | 3890 | 7450 |
| Industry | Life Insurance | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.1B |
| IPO Year | N/A | N/A |
| Metric | JXN | BIO |
|---|---|---|
| Price | $107.49 | $296.43 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $112.40 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 490.2K | 274.0K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.43% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.36 | $2.59 |
| Revenue Next Year | $3.38 | $3.21 |
| P/E Ratio | $16.00 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $69.84 | $211.43 |
| 52 Week High | $123.61 | $343.12 |
| Indicator | JXN | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.77 | 67.10 |
| Support Level | $104.99 | $293.88 |
| Resistance Level | $109.34 | $311.09 |
| Average True Range (ATR) | 3.04 | 7.44 |
| MACD | 0.50 | 2.67 |
| Stochastic Oscillator | 76.21 | 96.13 |
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.